tiprankstipranks
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market
1873
Viva Biotech Holdings
RESEARCH TOOLSreports

Viva Biotech Holdings (1873) Ratios

4 Followers

Viva Biotech Holdings Ratios

HK:1873's free cash flow for Q2 2025 was ¥0.41. For the 2025 fiscal year, HK:1873's free cash flow was decreased by ¥ and operating cash flow was ¥0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.50 1.67 1.32 0.73 2.14
Quick Ratio
 1.26 1.42 1.15 0.60 1.89
Cash Ratio
 0.79 0.84 0.68 0.25 0.86
Solvency Ratio
 0.13 0.11 0.02 -0.08 0.10
Operating Cash Flow Ratio
 0.25 0.33 0.25 0.14 0.08
Short-Term Operating Cash Flow Coverage
 0.36 0.68 0.40 0.20 0.33
Net Current Asset Value
¥ -1.08B¥ -1.36B¥ -1.73B¥ -2.38B¥ -2.15B
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.18 0.26 0.36 0.33
Debt-to-Equity Ratio
 0.33 0.34 0.52 0.78 0.68
Debt-to-Capital Ratio
 0.25 0.25 0.34 0.44 0.40
Long-Term Debt-to-Capital Ratio
 0.08 0.16 0.20 0.20 0.38
Financial Leverage Ratio
 1.80 1.85 2.02 2.20 2.06
Debt Service Coverage Ratio
 0.34 0.59 0.31 0.19 0.78
Interest Coverage Ratio
 6.91 4.26 1.09 1.46 1.29
Debt to Market Cap
 0.36 0.73 1.05 0.96 0.36
Interest Debt Per Share
 1.43 0.63 1.07 1.59 1.48
Net Debt to EBITDA
 0.57 0.80 2.22 4.91 5.01
Profitability Margins
Gross Profit Margin
37.93%34.60%34.26%34.28%30.94%
EBIT Margin
11.20%11.56%8.94%11.18%11.26%
EBITDA Margin
22.90%21.54%18.14%18.34%17.58%
Operating Profit Margin
11.20%11.56%8.94%11.32%11.26%
Pretax Profit Margin
18.41%14.88%-2.60%-19.30%16.53%
Net Profit Margin
12.72%8.42%-5.39%-22.21%13.67%
Continuous Operations Profit Margin
15.59%11.17%-4.63%-21.19%14.28%
Net Income Per EBT
69.12%56.57%207.52%115.09%82.70%
EBT Per EBIT
164.39%128.75%-29.04%-170.47%146.77%
Return on Assets (ROA)
3.03%2.37%-1.56%-6.67%3.57%
Return on Equity (ROE)
5.53%4.40%-3.15%-14.66%7.35%
Return on Capital Employed (ROCE)
3.32%3.88%3.26%5.13%3.33%
Return on Invested Capital (ROIC)
2.40%2.66%2.81%3.96%2.94%
Return on Tangible Assets
4.61%3.69%-2.38%-9.99%5.37%
Earnings Yield
13.51%9.69%-6.54%-18.12%3.92%
Efficiency Ratios
Receivables Turnover
 2.72 4.55 5.29 5.34 4.90
Payables Turnover
 5.01 4.20 5.77 4.80 5.17
Inventory Turnover
 3.17 4.76 5.46 4.80 6.27
Fixed Asset Turnover
 1.09 1.24 1.30 1.23 1.22
Asset Turnover
 0.24 0.28 0.29 0.30 0.26
Working Capital Turnover Ratio
 2.35 3.19 -18.19 14.71 1.15
Cash Conversion Cycle
 176.50 69.99 72.58 68.38 62.15
Days of Sales Outstanding
 134.12 80.29 68.99 68.41 74.54
Days of Inventory Outstanding
 115.20 76.61 66.89 76.09 58.21
Days of Payables Outstanding
 72.83 86.91 63.30 76.11 70.60
Operating Cycle
 249.33 156.90 135.88 144.50 132.75
Cash Flow Ratios
Operating Cash Flow Per Share
 0.37 0.18 0.20 0.20 0.04
Free Cash Flow Per Share
 0.23 0.09 0.10 0.07 -0.25
CapEx Per Share
 0.14 0.09 0.10 0.13 0.30
Free Cash Flow to Operating Cash Flow
 0.61 0.49 0.51 0.35 -6.26
Dividend Paid and CapEx Coverage Ratio
 2.56 1.95 2.04 1.55 0.13
Capital Expenditure Coverage Ratio
 2.56 1.95 2.04 1.55 0.14
Operating Cash Flow Coverage Ratio
 0.26 0.29 0.20 0.14 0.03
Operating Cash Flow to Sales Ratio
 0.21 0.19 0.18 0.16 0.04
Free Cash Flow Yield
5.98%10.56%11.01%4.69%-6.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 7.40 10.32 -15.29 -5.52 25.50
Price-to-Sales (P/S) Ratio
 2.09 0.87 0.82 1.23 3.48
Price-to-Book (P/B) Ratio
 0.40 0.45 0.48 0.81 1.87
Price-to-Free Cash Flow (P/FCF) Ratio
 16.73 9.47 9.08 21.33 -15.05
Price-to-Operating Cash Flow Ratio
 4.59 4.61 4.63 7.55 94.21
Price-to-Earnings Growth (PEG) Ratio
 0.08 -0.04 0.19 0.02 -0.16
Price-to-Fair Value
 0.40 0.45 0.48 0.81 1.87
Enterprise Value Multiple
 9.70 4.83 6.76 11.60 24.83
Enterprise Value
 3.81B 2.07B 2.64B 5.06B 9.19B
EV to EBITDA
 9.70 4.83 6.76 11.60 24.83
EV to Sales
 2.22 1.04 1.23 2.13 4.37
EV to Free Cash Flow
 17.76 11.34 13.51 37.02 -18.85
EV to Operating Cash Flow
 10.83 5.53 6.89 13.11 118.03
Tangible Book Value Per Share
 1.62 0.61 0.57 0.52 0.64
Shareholders’ Equity Per Share
 4.21 1.78 1.90 1.91 2.05
Tax and Other Ratios
Effective Tax Rate
 0.15 0.25 -0.78 -0.10 0.14
Revenue Per Share
 1.80 0.93 1.11 1.26 1.10
Net Income Per Share
 0.23 0.08 -0.06 -0.28 0.15
Tax Burden
 0.69 0.57 2.08 1.15 0.83
Interest Burden
 1.64 1.29 -0.29 -1.73 1.47
Research & Development to Revenue
 0.06 0.04 0.06 0.06 0.04
SG&A to Revenue
 0.21 0.18 0.13 0.11 0.11
Stock-Based Compensation to Revenue
 0.01 <0.01 <0.01 0.01 <0.01
Income Quality
 2.04 1.26 -6.85 -0.73 0.27
Currency in CNY